BRAF is a member of the Raf kinase family, and oncogenic mutations in BRAF activate the mitogen-activating protein kinase (MAPK)/extracellular signal-related kinase (ERK) kinase (MEK)→ERK signaling pathway, which is required for melanoma growth and metastasis10–12. This evidence concerns the gene MAP2K7 and melanoma.